The authors concluded that findings from studies with design limitations suggest that extra-anatomic bypass may not be the most appropriate 'gold' standard treatment for aortic graft infection. The authors' cautious conclusion appears appropriate in view of the limited evidence obtained from potentially biased, retrospective observational studies.
Data extraction
Two reviewers independently extracted event rates for the outcomes of interest from each study. The mean event rates with 95% confidence intervals (CIs) were calculated for each outcome.
Methods of synthesis
How were the studies combined? Data from studies that scored at least 18 out of 28 points for validity were pooled in meta-analyses. For each treatment, pooled mean event rates with 95% CIs were calculated for all outcomes combined and for each outcome using fixedeffect and random-effect models. The possibility of publication bias was examined using a funnel plot.
How were differences between studies investigated? Statistical heterogeneity was assessed using the Q statistic. Where heterogeneity was found, analyses were repeated after the exclusion of outliers. The studies were ranked in order of treatment effect for each outcome of interest, before and after tests of heterogeneity using fixed-effect analyses. A sensitivity analysis was used to examine the effect on the results of excluding the following studies: partial excisions formed 29% or fewer of all excisions performed; 41% or less cases were performed emergently; patients with aorto-enteric fistulas made up 44% or less of the study sample; the mean length of follow-up was 16.5 months or less; sepsis was reported in 44% or less of the study sample; and indication for aortic graft was occlusive disease in 70% or less of the study sample.
Results of the review
Thirty-seven retrospective observational studies were included. Some studies appeared to report results for more than one treatment. Twelve studies (n=459) evaluated extra-anatomic bypass, 5 studies (n=96) evaluated rifampicin-bonded prostheses, 16 studies (n=616) evaluated cryopreserved allografts and 9 studies (n=219) evaluated autogenous veins. One additional study (n=27) that evaluated silver coated polyester grafts was included in some tables but was not included in the meta-analyses.
All of the included studies scored 18 or more points for validity.
After tests for heterogeneity, overall event rates using fixed-effect models were highest for extra-anatomic bypass (0.16), followed by autogenous veins (0.10), cryopreserved allografts (0.09) and rifampicin-bonded prostheses (0.07). There was 'reasonable' heterogeneity (p>0.10) for all outcome measures across all treatments.
After tests for heterogeneity, event rates were lowest with rifampicin-bonded prostheses for amputations (0 versus 0.03 for cryopreserved allografts, 0.08 for autogenous veins and 0.08 for extra-anatomic bypass), conduit failures (0.02 versus 0.09 for cryopreserved allografts, 0.17 for autogenous veins and 0.25 for extra-anatomic bypass) and early mortality (0.07 versus 0.14 for cryopreserved allografts, 0.10 for autogenous veins and 0.18 for extra-anatomic bypass). Re-infection rates were greatest for rifampicin-bonded prostheses (0.07) and lowest for autogeneous veins (0.01) compared with cryopreserved allografts (0.03) and extra-anatomic bypass (0.06). Late mortality was lowest for autogenous veins and cryopreserved allografts (both 0.14) compared with rifampicin-bonded prostheses (0.16), and highest for extra-anatomic bypass (0.24).
There was little change in the results after sensitivity analyses.
Funnel plots suggested the absence of major publication bias.
Authors' conclusions
Findings from studies with design limitations suggest that extra-anatomic bypass may not be the most appropriate 'gold' standard treatment for aortic graft infection.
design. Limiting the search to studies reported in English in one database might have resulted in the omission of other relevant studies and an increased possibility of both language and publication bias. However, the authors assessed the potential for publication bias and found no evidence of it. Methods were used to minimise reviewer errors and bias in the assessment of validity and extraction of data, but it was unclear whether similar steps were taken at the study selection stage. Validity was assessed using specified criteria but the results were not reported.
The studies were pooled using meta-analysis, statistical heterogeneity was assessed, outliers were identified and sensitivity analyses were conducted. The evidence came from retrospective observational studies and these are subject to various potential biases; the results from these studies and any synthesis may not, therefore, be reliable. In addition, the main review results about the relative effect of different treatments were based on comparisons between subgroups of trials rather than direct comparisons within trials, thus any conclusions drawn about the relative effects should not be relied upon, especially given the level of heterogeneity between the studies. The authors' cautious conclusion appears appropriate in view of the considerable limitations of the evidence.
